US Edition
News from Amgen
Stay current with all the latest and breaking news about Amgen, compare headlines and perspectives between news sources on stories happening today. In total, 105 stories have been published about Amgen which Ground News has aggregated in the past 3 months.
Local News Publishers
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Amgen News
Amgen · Thousand OaksTHOUSAND OAKS, Calif., May 16, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 RBC Capital Markets Global Healthcare Conference at 9:00 a.m. ET on Wednesday, May 21, 2025. Kave Niksefat, senior vice president of Global Marketing and Access…See the Story
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
84% Center coverage: 12 sources
Donald Trump · United StatesLive Updates
Live Coverage Has Ended
Pharmaceutical Stocks are Still Erasing Earlier Losses
11:44 am
Following the initial shock from President Trump’s drug cost announcement, many of the top pharmaceutical stocks are still rebounding higher. Amgen (NASDAQ: AMGN), for example, is up more than 3.2%, or by $8.60 a share. AbbVie (NYSE: ABBV) is up just over 3.4%, or $6.35 a share. Bristol Myers Squibb (NYSE: BMY) is up just over 2.6%, or by $1.2…See the Story
Health Care Stocks (IBB) Live: President Trump Promises Lower Drug Prices, Stocks Moving
71% Center coverage: 7 sources
Alzheimer's DiseaseThe Alzheimer’s disease drugs that have reached the market in the past two years are antibodies designed to break up amyloid plaques. Vigil Neuroscience brings to Sanofi a different approach: an oral small molecule designed to activate microglia, immune cells that play a key role in brain health. The post Sanofi’s Neuro Pipeline Expands to Alzheimer’s With $470M Vigil Neuroscience Acquisition appeared first on MedCity News.See the Story
Sanofi’s Neuro Pipeline Expands to Alzheimer’s With $470M Vigil Neuroscience Acquisition
80% Center coverage: 5 sources
